HELEN OF TROY LTD (HELE)       119.2  -0.57 (-0.48%)

119.2  -0.57 (-0.48%)

BMG4388N1065 - Common Stock


Fundamental Rating

3

Taking everything into account, HELE scores 3 out of 10 in our fundamental rating. HELE was compared to 67 industry peers in the Household Durables industry. HELE scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. HELE has a expensive valuation and it also scores bad on growth




Profitability

Profitability Rating

1

HELE has a Piotroski-F score of 6.00. This indicates an average health and profitability for HELE.
HELE's Return On Assets of 4.69% is worse than the rest of the industry. The industry average Return On Assets is 12.01%. 87% of the industry peers have a better Return On Assets.

HELE has a Return On Equity of 10.08%. This is below the industry average of 23.94%. 91% of the industry peers outperform HELE.
HELE has a Profit Margin of 6.77%. This is below the industry average of 11.33%.
VS Industry

ROA (4.69%) VS Industry: 13% outperformed.

0.19
30.48

ROE (10.08%) VS Industry: 9% outperformed.

0.37
56.15

Profit Margin (6.77%) VS Industry: 27% outperformed.

0.17
68.16

Valuation

Valuation Rating

3

The Price/Earnings Ratio is 11.99, which indicates a very decent valuation of HELE.
HELE's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a Forward Price/Earnings Ratio of 12.04, HELE is valued correctly.
When comparing the current price to the book value of HELE, we can conclude it is valued correctly. It is trading at 1.96 times its book value.

HELE's Price/Earning Ratio is slightly more expensive than the industry average, which is at 7.63.
When comparing the price book ratio of HELE to the average industry price book ratio of 1.42, HELE is valued more expensive than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of HELE to the average industry ratio of 6.73, HELE is valued more expensive than its industry peers.
VS Industry

Price/Earnings (11.99) VS Industry: 29% outperformed.

173.00
2.18

Price/Book (1.96) VS Industry: 26% outperformed.

11.35
0.08

Enterprise Value/ EBITDA (13.46) VS Industry: 21% outperformed.

518.09
1.94

Growth

Growth Rating

3

The Earnings Per Share has been growing by 12.93% on average over the past 5 years. This is quite good.
The Earnings Per Share is expected to decrease by -1.79% on average over the next 5 years.
Looking at the last year, HELE shows a small growth in Revenue. The Revenue has grown by 0.90% in the last year.
The Revenue has been growing slightly by 9.73% on average over the past 5 years.

The Revenue is expected to grow by 1.21% on average over the next 5 years.
The earnings per share for HELE have decreased strongly by -12.96% in the last year.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS12.93% 15.27% -12.96% -24.14% -10.49% -1.79% N/A
Revenue9.73% 12.44% 0.9% -3.76% -0.28% 1.21% N/A

Health

Health Rating

4

A Current Ratio of 2.15 indicates that HELE has no problem at all paying its short term obligations.
When comparing the Quick Ratio to an average industry Quick Ratio of 0.83, HELE is better placed than the average industry peer to meet its short term obligations.
HELE has a Current Ratio comparable to the industry average, which is at 2.50.
A Quick Ratio of 1.12 indicates that HELE should not have too much problems paying its short term obligations.

An Altman-Z score of 2.72 indicates that HELE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Piotroski-F score of HELE is 6.00. This is a neutral score and indicates average health and profitability for HELE.
When comparing the Debt to Equity Ratio of HELE to the average industry Debt to Equity Ratio of 0.29, HELE required more debt to finance its operations than its industry peers.
Compared to an average industry Altman-Z score of 3.13, HELE is in worse financial health than its industry peers.
VS Industry

Debt/Equity (0.73) VS Industry: 23% outperformed.

3.37
0.00

Quick Ratio (1.12) VS Industry: 66% outperformed.

0.07
11.78

Current Ratio (2.15) VS Industry: 45% outperformed.

0.20
13.36

Altman-Z (2.72) VS Industry: 39% outperformed.

-16.00
14.21

Dividend

Dividend Rating

0

HELE does not give a dividend.

HELEN OF TROY LTD119.2

NASDAQ:HELE (2/6/2023, 1:18:49 PM)-0.57 (-0.48%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Consumer Durables & Apparel
GICS Industry Household Durables
Earnings (Last) 01-05 2023-01-05/bmo Earnings (Next) 04-25 2023-04-25/amc
Inst Owners 93.58% Inst Owner Change 0.34%
Ins Owners 0.59% Ins Owner Change 2.46%
Market Cap 2.86B Analysts 81.67
Price Target 154.02 (29.21%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 2.12%
Min EPS beat(2) 0.8% Max EPS beat(2) 3.44%
EPS beat(4) 4 Avg EPS beat(4) 8.95%
Min EPS beat(4) 0.8% Max EPS beat(4) 22.32%
Revenue beat(2) N/A Avg Revenue beat(2) -1.17%
Min Revenue beat(2) -1.4% Max Revenue beat(2) -0.95%
Revenue beat(4) 2 Avg Revenue beat(4) 5.37%
Min Revenue beat(4) -1.4% Max Revenue beat(4) 20.99%
PT rev (1m) 5.45% PT rev (3m) -1.15%
EPS NQ rev (1m) -42.02% EPS NQ rev (3m) -40.61%
EPS NY rev (1m) 0% EPS NY rev (3m) 0.08%
Revenue NQ rev (1m) -18.55% Revenue NQ rev (3m) -18.19%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.04%

Valuation
Industry RankSector Rank
PE 11.99
Fwd PE 12.04
P/S 1.32
P/FCF 225.26
P/OCF 14.64
P/B 1.96
P/tB N/A
EV/EBITDA 13.46
EPS(TTM) 9.94 EY 8.34%
EPS(NY) 9.9 Fwd EY 8.31%
FCF(TTM) 0.53 FCFY 0.44%
OCF(TTM) 8.14 OCFY 6.83%
SpS 90.45 BVpS 60.73
TBVpS -6.86 PEG (NY) N/A
PEG (5Y) 0.93

Profitability
Industry RankSector Rank
ROA 4.69%
ROE 10.08%
ROIC 8.39%
ROICexc 8.54%
ROICexgc 23.27%
OM 11.39%
PM 6.77%
GM 43.98%
ROICexgc(3y) 41.48% ROICexcg growth 3Y -5.97%
ROICexcg growth 5Y 4.73% ROICexc(3y) 13.26%
ROICexc growth 3Y -6.49% ROICexc growth 5Y 1.51%
OM growth 3Y -1.72% OM growth 5Y -0.24%
PM growth 3Y -2.24% PM growth 5Y -0.01%
GM growth 3Y 1.51% GM growth 5Y 0.88%
F-Score 6 Asset Turnover 0.69

Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 85.1
Debt/EBITDA 3.72
Cap/Depr 424.13%
Profit Quality 8.64%
Current Ratio 2.15
Quick Ratio 1.12
Altman-Z 2.72
F-Score 6 WACC 8.53%
ROIC/WACC 2.73 Cap/Depr(3y) 175.74%
Cap/Depr(5y) 131.17% Profit Quality(3y) 93.11%
Profit Quality(5y) 170.78%

Growth
EPS 1Y -12.96% EPS 3Y 15.27%
EPS 5Y 12.93% EPS growth Q2Q -26.08%
EPS Next Y -24.14% EPS Next 2Y -10.49%
EPS Next 3Y -1.79% EPS Next 5Y N/A
Revenue growth 1Y 0.9% Revenue growth 3Y 12.44%
Revenue growth 5Y 9.73% Revenue growth Q2Q -10.61%
Revenue Next Year -3.76% Revenue Next 2Y -0.28%
Revenue Next 3Y 1.21% Revenue Next 5Y N/A
EBIT growth 1Y -3.2% EBIT growth 3Y 10.5%
EBIT growth 5Y 9.47% EBIT Next Year -2.93%
EBIT Next 3Y 5.69% EBIT Next 5Y N/A
FCF growth 1Y -96.79% FCF growth 3Y -28.1%
FCF growth 5Y -21.68% OCF growth 1Y -53.43%
OCF growth 3Y -10.33% OCF growth 5Y -9.23%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA